Targeted gene therapy shuts down cancer cells’ energy centers

Fampyra used to see sales of over $500m in 2017, but sales weakened after generics entered the market. Image credit: Shutterstock / Elena Abrazhevich. Merz

Fed­er­al judges have blocked two Flori­da well­ness cen­ters from us­ing No­vo Nordisk’s trade­mark to mar­ket com­pound­ed drugs con­tain­ing its di­a­betes and weight loss block­buster semaglu­tide.